Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATRI Atrion	$459.92	$459.06	$274.98 ▼ $503.24	$809.46M	0.69	23,283 shs	N/A
CRY CryoLife		$19.05	$16.95 ▼ $32.34	$703.22M	1.53	198,221 shs	7,792 shs
KIDS OrthoPediatrics	$22.14 +1.1%	$21.55	$19.52 ▼ $35.99	$537.78M	1.1	198,592 shs	92,601 shs
LMAT LeMaitre Vascular	$84.09 +0.5%	$82.72	$71.42 ▼ $109.58	$1.90B	0.82	169,831 shs	73,227 shs
MDXG MiMedx Group	$6.80 +2.1%	$6.52	$5.47 ▼ $10.14	$1.00B	1.76	688,873 shs	1.12 million shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATRI Atrion	0.00%	0.00%	0.00%	0.00%	+0.95%
CRY CryoLife	0.00%	0.00%	0.00%	0.00%	0.00%
KIDS OrthoPediatrics	+1.14%	+4.24%	+4.63%	+5.58%	-32.40%
LMAT LeMaitre Vascular	+0.49%	+1.34%	+3.65%	-0.64%	-2.28%
MDXG MiMedx Group	+2.10%	+4.94%	+12.58%	0.00%	-4.63%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ATRI Atrion	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CRY CryoLife	1.3179 of 5 stars	0.0	0.0	0.0	3.7	0.6	1.7	1.9
KIDS OrthoPediatrics	4.2895 of 5 stars	3.4	2.0	0.0	3.9	2.7	3.3	0.6
LMAT LeMaitre Vascular	2.2831 of 5 stars	2.2	1.0	3.3	0.0	1.6	2.5	1.3
MDXG MiMedx Group	3.8137 of 5 stars	3.5	2.0	0.0	0.0	3.6	3.3	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATRI Atrion	0.00	N/A	N/A	N/A
CRY CryoLife	0.00	N/A	N/A	N/A
KIDS OrthoPediatrics	2.83	Moderate Buy	$35.83	61.85% Upside
LMAT LeMaitre Vascular	2.33	Hold	$97.83	16.34% Upside
MDXG MiMedx Group	3.00	Buy	$12.50	83.82% Upside

Current Analyst Ratings Breakdown

Latest LMAT, KIDS, MDXG, CRY, and ATRI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
5/8/2025	KIDS OrthoPediatrics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$40.00 ➝ $30.00
5/8/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00

(Data available from 7/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATRI Atrion	$181.60M	4.46	$19.68 per share	23.37	$138.02 per share	3.33
CRY CryoLife	$253.23M	0.00	N/A	23.30	$8.46 per share	0.00
KIDS OrthoPediatrics	$204.73M	2.63	N/A	N/A	$14.64 per share	1.51
LMAT LeMaitre Vascular	$226.26M	8.40	$2.40 per share	35.03	$15.00 per share	5.61
MDXG MiMedx Group	$348.88M	2.88	$0.34 per share	20.10	$1.31 per share	5.19

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATRI Atrion	$19.41M	$10.64	43.23	∞	N/A	10.60%	7.75%	7.12%	N/A
CRY CryoLife	-$16.68M	$0.03	596.20	0.00	N/A	0.63%	4.24%	1.63%	N/A
KIDS OrthoPediatrics	-$37.82M	-$1.75	N/A	N/A	N/A	-19.15%	-7.03%	-5.45%	8/4/2025 (Estimated)
LMAT LeMaitre Vascular	$44.04M	$1.98	42.47	38.75	2.21	19.96%	13.53%	9.78%	8/5/2025 (Estimated)
MDXG MiMedx Group	$42.42M	$0.27	25.19	21.25	N/A	11.40%	22.70%	16.77%	7/30/2025 (Estimated)

Latest LMAT, KIDS, MDXG, CRY, and ATRI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2025	Q2 2025	LMAT LeMaitre Vascular	$0.57	N/A	N/A	N/A	$62.48 million	N/A
8/4/2025	Q2 2025	KIDS OrthoPediatrics	-$0.17	N/A	N/A	N/A	$61.40 million	N/A
7/30/2025	Q2 2025	MDXG MiMedx Group	$0.06	N/A	N/A	N/A	$90.79 million	N/A
5/7/2025	Q1 2025	KIDS OrthoPediatrics	-$0.26	-$0.39	-$0.13	-$0.46	$51.68 million	$52.41 million
5/1/2025	Q1 2025	LMAT LeMaitre Vascular	$0.50	$0.48	-$0.02	$0.48	$57.61 million	$59.87 million
4/30/2025	Q1 2025	MDXG MiMedx Group	$0.06	$0.06	N/A	$0.05	$86.32 million	$88.21 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATRI Atrion	$8.80	1.91%	N/A	82.71%	21 Years
CRY CryoLife	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
LMAT LeMaitre Vascular	$0.80	0.95%	N/A	40.40%	14 Years
MDXG MiMedx Group	N/A	N/A	N/A	N/A	N/A

Latest LMAT, KIDS, MDXG, CRY, and ATRI Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/29/2025	LMAT LeMaitre Vascular	quarterly	$0.20	1%	5/15/2025	5/15/2025	5/29/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATRI Atrion	N/A	9.18	3.06
CRY CryoLife	0.99	4.21	2.93
KIDS OrthoPediatrics	0.21	6.19	2.99
LMAT LeMaitre Vascular	0.48	16.49	13.83
MDXG MiMedx Group	0.09	4.70	4.13

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ATRI Atrion	66.19%
CRY CryoLife	81.57%
KIDS OrthoPediatrics	69.05%
LMAT LeMaitre Vascular	84.64%
MDXG MiMedx Group	79.15%

Insider Ownership

Company	Insider Ownership
ATRI Atrion	22.82%
CRY CryoLife	4.50%
KIDS OrthoPediatrics	31.80%
LMAT LeMaitre Vascular	9.50%
MDXG MiMedx Group	1.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ATRI Atrion	720	1.76 million	1.36 million	Not Optionable
CRY CryoLife	1,200	39.33 million	37.56 million	Optionable
KIDS OrthoPediatrics	200	24.29 million	16.56 million	Optionable
LMAT LeMaitre Vascular	490	22.59 million	20.45 million	Optionable
MDXG MiMedx Group	870	147.70 million	145.19 million	Optionable

LMAT, KIDS, MDXG, CRY, and ATRI Headlines

Recent News About These Companies

Allspring Global Investments Holdings LLC Sells 65,036 Shares of MiMedx Group, Inc (NASDAQ:MDXG)

July 11, 2025 | marketbeat.com

Strength Seen in MiMedx (MDXG): Can Its 8.0% Jump Turn into More Strength?

July 9, 2025 | zacks.com

MDXG MiMedx Group, Inc. - Seeking Alpha

June 29, 2025 | seekingalpha.com

Director Of MiMedx Group Makes $185K Buy - Nasdaq

June 26, 2025 | nasdaq.com

Positive Signal: James L Bierman Shows Faith, Buying $185K In MiMedx Group Stock

June 24, 2025 | benzinga.com

Director Of MiMedx Group Makes $185K Buy

June 24, 2025 | benzinga.com

MIMEDX to Participate in Upcoming Investor Conferences

May 27, 2025 | globenewswire.com

Monday 5/5 Insider Buying Report: MDXG, HLMN

May 7, 2025 | nasdaq.com

Zooming In On MiMedx Group's Earnings

May 7, 2025 | finance.yahoo.com

MIMEDX to Present at the BofA Securities 2025 Healthcare Conference

May 6, 2025 | globenewswire.com

Insider Buying: MiMedx Group, Inc. (NASDAQ:MDXG) CEO Acquires 200,000 Shares of Stock

May 6, 2025 | insidertrades.com

MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)

May 5, 2025 | globenewswire.com

US$12.20: That's What Analysts Think MiMedx Group, Inc. (NASDAQ:MDXG) Is Worth After Its Latest Results

May 3, 2025 | finance.yahoo.com

MiMedx Group, Inc. (NASDAQ:MDXG) Q1 2025 Earnings Call Transcript

May 2, 2025 | msn.com

MiMedx Group, Inc: MIMEDX Announces First Quarter 2025 Operating and Financial Results

May 1, 2025 | finanznachrichten.de

MiMedx projects high single-digit revenue growth in 2025 with strong surgical market advances

May 1, 2025 | msn.com

MiMedx Group Inc (MDXG) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges

May 1, 2025 | finance.yahoo.com

MiMedx Group, Inc. (MDXG) Q1 2025 Earnings Call Transcript

April 30, 2025 | seekingalpha.com

MiMedx (MDXG) Q1 Earnings Match Estimates

April 30, 2025 | zacks.com

MIMEDX Announces First Quarter 2025 Operating and Financial Results

April 30, 2025 | globenewswire.com

MiMedx price target lowered to $15 from $16 at Mizuho

April 16, 2025 | markets.businessinsider.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
By Gabriel Osorio-Mazilli | June 30, 2025
View Why BigBear.ai Could Rally 100% and Catch Palantir Soon
3 Defense Leaders Set to Gain From Rising Military Spend
By Chris Markoch | July 5, 2025
View 3 Defense Leaders Set to Gain From Rising Military Spend
IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
Why Now Could Be the Smartest Time to Buy Crypto Stocks
By Nathan Reiff | July 10, 2025
View Why Now Could Be the Smartest Time to Buy Crypto Stocks
Believe the Hype? Can SoFi Maintain Its 3-Month Rally?
By Nathan Reiff | July 8, 2025
View Believe the Hype? Can SoFi Maintain Its 3-Month Rally?

LMAT, KIDS, MDXG, CRY, and ATRI Company Descriptions

Atrion NASDAQ:ATRI

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

CryoLife NYSE:CRY

CryoLife, Inc. engages in the manufacture, process and distribution of medical devices and implantable human tissues. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes revenues from sales of BioGlue products, aortic stents and stent grafts, On-X products, CardioGenesis cardiac laser therapy, PerClot, and PhotoFix. The Preservation Services segment focuses on revenues from preservation of cardiac and vascular implantable human tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.

OrthoPediatrics NASDAQ:KIDS

$22.14 +0.25 (+1.14%)

Closing price 07/14/2025 04:00 PM Eastern

Extended Trading

$22.14 0.00 (0.00%)

As of 07/14/2025 04:10 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

LeMaitre Vascular NASDAQ:LMAT

$84.09 +0.41 (+0.49%)

Closing price 07/14/2025 04:00 PM Eastern

Extended Trading

$84.09 0.00 (0.00%)

As of 07/14/2025 04:55 PM Eastern

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

MiMedx Group NASDAQ:MDXG

$6.80 +0.14 (+2.10%)

Closing price 07/14/2025 04:00 PM Eastern

Extended Trading

$5.38 -1.42 (-20.81%)

As of 07/14/2025 07:59 PM Eastern

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest LMAT, KIDS, MDXG, CRY, and ATRI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest LMAT, KIDS, MDXG, CRY, and ATRI Earnings

Compare Dividends

Latest LMAT, KIDS, MDXG, CRY, and ATRI Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

LMAT, KIDS, MDXG, CRY, and ATRI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

LMAT, KIDS, MDXG, CRY, and ATRI Company Descriptions

Atrion NASDAQ:ATRI

CryoLife NYSE:CRY

OrthoPediatrics NASDAQ:KIDS

LeMaitre Vascular NASDAQ:LMAT

MiMedx Group NASDAQ:MDXG

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools